Efpeglenatide

DB15650InvestigationalProtein Based Therapies

Efpeglenatide is under investigation in clinical trial NCT03713684 (Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in...

Mechanism: Pharmacologically active on Glucagon-like peptide 1 receptor
Curator reviewed
Also known as: Langlenatide
Code names: HM-11260C · SAR-439977

Resolves to

Compound

UNII3M1V5Z2270CAS1296200-77-5

Targets

P43220GLP1R

What you can answer from here — as of July 11, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Efpeglenatide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account